ASTERA LABS INC (ALAB) Fundamental Analysis & Valuation

NASDAQ:ALAB • US04626A1034

Current stock price

100.27 USD
-12.2 (-10.85%)
At close:
99.75 USD
-0.52 (-0.52%)
Pre-Market:

This ALAB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. ALAB Profitability Analysis

1.1 Basic Checks

  • ALAB had positive earnings in the past year.
  • In the past year ALAB had a positive cash flow from operations.
ALAB Yearly Net Income VS EBIT VS OCF VS FCFALAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • ALAB has a better Return On Assets (14.31%) than 86.09% of its industry peers.
  • The Return On Equity of ALAB (16.07%) is better than 81.74% of its industry peers.
  • With an excellent Return On Invested Capital value of 9.79%, ALAB belongs to the best of the industry, outperforming 80.87% of the companies in the same industry.
Industry RankSector Rank
ROA 14.31%
ROE 16.07%
ROIC 9.79%
ROA(3y)-2.33%
ROA(5y)N/A
ROE(3y)-3.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALAB Yearly ROA, ROE, ROICALAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • ALAB's Profit Margin of 25.70% is amongst the best of the industry. ALAB outperforms 84.35% of its industry peers.
  • ALAB has a Operating Margin of 20.34%. This is in the better half of the industry: ALAB outperforms 79.13% of its industry peers.
  • With an excellent Gross Margin value of 75.69%, ALAB belongs to the best of the industry, outperforming 94.78% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ALAB has remained more or less at the same level.
Industry RankSector Rank
OM 20.34%
PM (TTM) 25.7%
GM 75.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5YN/A
ALAB Yearly Profit, Operating, Gross MarginsALAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. ALAB Health Analysis

2.1 Basic Checks

  • ALAB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, ALAB has more shares outstanding
  • There is no outstanding debt for ALAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ALAB Yearly Shares OutstandingALAB Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 50M 100M 150M
ALAB Yearly Total Debt VS Total AssetsALAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 62.79 indicates that ALAB is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 62.79, ALAB belongs to the best of the industry, outperforming 97.39% of the companies in the same industry.
  • There is no outstanding debt for ALAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 62.79
ROIC/WACC0.84
WACC11.6%
ALAB Yearly LT Debt VS Equity VS FCFALAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • ALAB has a Current Ratio of 10.24. This indicates that ALAB is financially healthy and has no problem in meeting its short term obligations.
  • ALAB's Current ratio of 10.24 is amongst the best of the industry. ALAB outperforms 92.17% of its industry peers.
  • ALAB has a Quick Ratio of 9.79. This indicates that ALAB is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of ALAB (9.79) is better than 92.17% of its industry peers.
Industry RankSector Rank
Current Ratio 10.24
Quick Ratio 9.79
ALAB Yearly Current Assets VS Current LiabilitesALAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. ALAB Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 84.00% over the past year.
  • ALAB shows a strong growth in Revenue. In the last year, the Revenue has grown by 115.13%.
  • Measured over the past years, ALAB shows a very strong growth in Revenue. The Revenue has been growing by 120.18% on average per year.
EPS 1Y (TTM)84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.76%
Revenue 1Y (TTM)115.13%
Revenue growth 3Y120.18%
Revenue growth 5YN/A
Sales Q2Q%91.77%

3.2 Future

  • ALAB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.04% yearly.
  • Based on estimates for the next years, ALAB will show a very strong growth in Revenue. The Revenue will grow by 21.07% on average per year.
EPS Next Y34.94%
EPS Next 2Y38.18%
EPS Next 3Y35.37%
EPS Next 5Y35.04%
Revenue Next Year61.78%
Revenue Next 2Y49.37%
Revenue Next 3Y41.59%
Revenue Next 5Y21.07%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALAB Yearly Revenue VS EstimatesALAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
ALAB Yearly EPS VS EstimatesALAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

2

4. ALAB Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 54.49, the valuation of ALAB can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of ALAB is on the same level as its industry peers.
  • ALAB is valuated expensively when we compare the Price/Earnings ratio to 24.75, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 40.39, the valuation of ALAB can be described as expensive.
  • ALAB's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 22.10. ALAB is valued rather expensively when compared to this.
Industry RankSector Rank
PE 54.49
Fwd PE 40.39
ALAB Price Earnings VS Forward Price EarningsALAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALAB.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as ALAB.
Industry RankSector Rank
P/FCF 60.57
EV/EBITDA 82.42
ALAB Per share dataALAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • ALAB's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ALAB's earnings are expected to grow with 35.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.56
PEG (5Y)N/A
EPS Next 2Y38.18%
EPS Next 3Y35.37%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALAB Dividend Analysis

5.1 Amount

  • No dividends for ALAB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALAB Fundamentals: All Metrics, Ratios and Statistics

ASTERA LABS INC

NASDAQ:ALAB (3/30/2026, 8:00:01 PM)

Premarket: 99.75 -0.52 (-0.52%)

100.27

-12.2 (-10.85%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-10
Earnings (Next)05-04
Inst Owners79.38%
Inst Owner Change3.11%
Ins Owners10.44%
Ins Owner Change-6.11%
Market Cap17.07B
Revenue(TTM)852.52M
Net Income(TTM)219.13M
Analysts80.71
Price Target208.67 (108.11%)
Short Float %8.95%
Short Ratio2.6
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.96%
Min EPS beat(2)10.58%
Max EPS beat(2)23.34%
EPS beat(4)4
Avg EPS beat(4)20.27%
Min EPS beat(4)10.58%
Max EPS beat(4)33.19%
EPS beat(8)8
Avg EPS beat(8)91.39%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.89%
Min Revenue beat(2)6.34%
Max Revenue beat(2)9.44%
Revenue beat(4)4
Avg Revenue beat(4)6.73%
Min Revenue beat(4)2.08%
Max Revenue beat(4)9.44%
Revenue beat(8)8
Avg Revenue beat(8)8.2%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.18%
PT rev (3m)1.31%
EPS NQ rev (1m)-0.17%
EPS NQ rev (3m)3.42%
EPS NY rev (1m)3.04%
EPS NY rev (3m)3.5%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)12.78%
Revenue NY rev (1m)0.81%
Revenue NY rev (3m)11.91%
Valuation
Industry RankSector Rank
PE 54.49
Fwd PE 40.39
P/S 20.02
P/FCF 60.57
P/OCF 53.45
P/B 12.52
P/tB 12.52
EV/EBITDA 82.42
EPS(TTM)1.84
EY1.84%
EPS(NY)2.48
Fwd EY2.48%
FCF(TTM)1.66
FCFY1.65%
OCF(TTM)1.88
OCFY1.87%
SpS5.01
BVpS8.01
TBVpS8.01
PEG (NY)1.56
PEG (5Y)N/A
Graham Number18.21
Profitability
Industry RankSector Rank
ROA 14.31%
ROE 16.07%
ROCE 12.4%
ROIC 9.79%
ROICexc 65.25%
ROICexgc 65.25%
OM 20.34%
PM (TTM) 25.7%
GM 75.69%
FCFM 33.05%
ROA(3y)-2.33%
ROA(5y)N/A
ROE(3y)-3.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5YN/A
F-Score6
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 549.77%
Cap/Sales 4.4%
Interest Coverage 250
Cash Conversion 177.14%
Profit Quality 128.58%
Current Ratio 10.24
Quick Ratio 9.79
Altman-Z 62.79
F-Score6
WACC11.6%
ROIC/WACC0.84
Cap/Depr(3y)596.85%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.14%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.76%
EPS Next Y34.94%
EPS Next 2Y38.18%
EPS Next 3Y35.37%
EPS Next 5Y35.04%
Revenue 1Y (TTM)115.13%
Revenue growth 3Y120.18%
Revenue growth 5YN/A
Sales Q2Q%91.77%
Revenue Next Year61.78%
Revenue Next 2Y49.37%
Revenue Next 3Y41.59%
Revenue Next 5Y21.07%
EBIT growth 1Y249.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year48.09%
EBIT Next 3Y41.83%
EBIT Next 5Y41.19%
FCF growth 1Y175.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y133.62%
OCF growth 3YN/A
OCF growth 5YN/A

ASTERA LABS INC / ALAB Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ASTERA LABS INC?

ChartMill assigns a fundamental rating of 6 / 10 to ALAB.


Can you provide the valuation status for ASTERA LABS INC?

ChartMill assigns a valuation rating of 2 / 10 to ASTERA LABS INC (ALAB). This can be considered as Overvalued.


How profitable is ASTERA LABS INC (ALAB) stock?

ASTERA LABS INC (ALAB) has a profitability rating of 5 / 10.


Can you provide the financial health for ALAB stock?

The financial health rating of ASTERA LABS INC (ALAB) is 8 / 10.